Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors [Phase 1, Phase 2]
An ongoing Phase 1/2 study investigates systemic VSV-IFNβ-NIS in combination with checkpoint inhibitors for select solid tumors. The trial i…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Primary Tumor Resection Plus Osimertinib in Advanced EGFR-mutant Non-small Cell Lung Cancer [Phase 2]
This clinical trial update describes a Phase 2 study of adding primary tumor resection to osimertinib in advanced EGFR-mutant non-small cell…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Primary Tumor Resection With Sintilimab and Chemotherapy in Advanced NSCLC [Phase 2]
Phase 2 trial investigating primary tumor resection with sintilimab and chemotherapy in advanced non-small cell lung cancer; the study is no…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: SRS for NSCLC With Oligo-residual Intracranial Disease After First-line 3rd Generation EGFR-TKI [Phase 2]
Clinical trial update on stereotactic radiosurgery for brain metastases in non-small cell lung cancer after a first-line third-generation EG…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: First-line Immunotherapy-based Standard of Care and Local Ablative Treatments for Oligometastatic Non-small Cell Lung Cancer Patients. [Phase 3]
A Phase 3 trial is investigating upfront immunotherapy-based standard of care combined with local ablative therapies for oligometastatic non…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Deciphering Mechanisms Underlying Cancer Immunogenicity [NA]
A clinical trial exploring mechanisms underlying cancer immunogenicity, sponsored by Institut Claudius Regaud; the study is currently recrui…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial update for GI-108, a bispecific anti-CD73-IL-2v fusion protein, being studied as monotherapy in advanced or metasta…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors
Real-world study evaluating adebrelimab-based combination regimens for advanced solid tumors. The conditions include non-small cell lung can…
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports a Phase 1/2 study of YL202 in combination with other anti-tumor therapies for patients with advanced soli…
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: A Retrospective Observational Study of Nivolumab in Combination With Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC Patients: Real-World Experience in Taiwan (NEOREAL)
An observational real-world study from Taiwan is evaluating nivolumab in combination with chemotherapy as neoadjuvant therapy for resectable…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Fissios© and Postoperative Complications (FPoC Trial) [NA]
This document provides an update on the Fissios© Postoperative Complications (FPoC) Trial, sponsored by Carlos Alfredo Fraile Olivero, MD, P…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial [Phase 2]
This entry announces a Phase II randomized, double-blind trial of RMT in combination with Durvalumab and chemotherapy in untreated non-small…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Personalized SBRT in Early-Stage Peripheral NSCLC [Phase 2]
This is a Phase 2 clinical trial update for personalized SBRT in early-stage peripheral non-small cell lung cancer, currently enrolling by i…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Immunotherapy Clearance and Phenotype of Circulating Tumor Cells in Lung and Head and Neck Cancers [NA]
Clinical trial update on immunotherapy and circulating tumor cell phenotyping in metastatic non-small cell lung cancer and metastatic head a…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT [Phase 3]
A Phase III randomized trial is evaluating upfront cranial radiotherapy versus observation in patients with oncogene-mutated non-small cell …
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC [Phase 2]
Overview of a Phase 2 trial comparing local consolidative radiation therapy added to a tyrosine kinase inhibitor versus TKI alone in driver-…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Efficacy of Neoadjuvant Immunotherapy in Patients With Lung Cancer
An ongoing clinical trial from the Chinese Academy of Medical Sciences is evaluating the efficacy of neoadjuvant immunotherapy in patients w…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Glecirasib [Phase 2]
A Phase 2 clinical trial evaluating ABSK043 in combination with Glecirasib for non-small cell lung cancer is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors [Phase 1]
Phase 1 trial update evaluating AB248 alone or with pembrolizumab in adults with solid tumors, including non-small cell lung cancer, melanom…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 trial evaluating Belrestotug plus dostarlimab vs placebo plus pembrolizumab in untreated PD-L1-high non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Standard Maintenance Therapy (SMT) vs Local Consolidative Radiation Therapy and SMT in OM-NSCLC [Phase 3]
This is a Phase 3 clinical trial comparing Standard Maintenance Therapy alone versus SMT plus local consolidative radiation therapy in oligo…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer [Phase 1, Phase 2]
This clinical trial update describes a Phase I/II study evaluating hypofractionated proton therapy for stage II-III non-small cell lung canc…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
This document outlines a Phase 3 pharmacokinetic comparison trial evaluating QL2107 versus Keytruda (pembrolizumab) as adjuvant therapy for …
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression [Phase 1, Phase 2]
A2 Biotherapeutics is evaluating A2B395, an allogeneic logic-gated CAR T therapy, in Phase 1/2 trials for solid tumors expressing EGFR and l…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: A Study of NX-1607 in Adults With Advanced Malignancies [Phase 1]
A Phase 1 study evaluating NX-1607 in adults with advanced malignancies is actively recruiting across multiple tumor types, including ovaria…